Celldex Therapeutics | CLDX - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
AbbVie USD 12.54B 474M 2026-03
Agenus USD 34.2M 4.61M 2025-12
Amgen USD 6.89B 415M 2025-12
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Celldex Therapeutics USD 121K 609K 2025-12
Glaxosmithkline GBP 8.75B 2.92B 2025-09
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Pfizer USD 11.04B 1.24B 2026-03
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Roche Holding CHF 22.09B 10.04B 2025-12